Add BrightSurf on Google Email

Science News Archive September 2025 - Page 46


Page 46 of 54

Batteries make 12minute charge for 800km drive a reality​

Researchers at KAIST have developed a new liquid electrolyte that significantly improves lithium-metal battery performance, enabling fast charging times of just 12 minutes and an 800km driving range. The breakthrough overcomes the long-standing dendrite problem, a major barrier to widespread adoption of lithium-metal batteries.

SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalNature Energy·TypeMeta-analysis·DateSep 4, 2025

“I want to get some bad-ass tattoos”: Study reveals why suicidal teens choose to keep living

A new study has identified the deeply personal reasons that suicidal adolescents give for wanting to live, with family connections being the most common reason. Young people also spoke about personal dreams, simple joys, and meaningful activities, such as getting a tattoo, as reasons to keep living.

SourceCity St George’s, University of London·JournalPsychiatric Services·TypeObservational study·DateSep 4, 2025

One dose of penicillin is as effective as standard three doses in treating early syphilis, according to UAB-led study

Researchers at UAB have published a study suggesting one dose of benzathine penicillin G is as effective as the three-injection regimen at treating early syphilis. The study found that one dose is sufficient to treat patients, reducing time and inconvenience associated with multiple injections.

SourceUniversity of Alabama at Birmingham·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateSep 4, 2025

Digitoxin improves outcomes in advanced heart failure

The DIGIT-HF trial found that digitoxin significantly reduced the risk of composite mortality and hospitalisation for worsening heart failure among patients with advanced heart failure and reduced ejection fraction. Patients who received digitoxin had a lower rate of all-cause death and hospitalisations compared to those on placebo.

SourceEuropean Society of Cardiology·JournalNew England Journal of Medicine·DateSep 4, 2025

Sizing up a weakness in synovial sarcoma’s genes

Researchers at Sanford Burnham Prebys Medical Discovery Institute found that using a drug as a blocker to outcompete the SUMO2 protein may be a winning strategy against synovial sarcoma. This approach aims to reverse aberrant epigenetic rewiring driven by the SS18::SSX fusion oncoproteins and impair sarcomagenesis.

SourceSanford Burnham Prebys·JournalThe EMBO Journal·TypeExperimental study·DateSep 4, 2025

Deep learning meets jet imaging for faster, smarter sludge moisture monitoring

Researchers have developed a system that captures high-speed jet images of activated sludge to predict moisture content with remarkable accuracy in under 20 seconds. The convolutional neural network (CNN) model VGG-16 emerged as the most effective for moisture prediction, achieving impressive validation results.

SourceChinese Society for Environmental Sciences·JournalEnvironmental Science and Ecotechnology·DateSep 4, 2025

International research team unlocks the power of passivation for perovskite silicon tandem solar cells

Researchers achieved excellent passivation of perovskite top cells on textured silicon surfaces, leading to improved efficiency and conductivity. The breakthrough enhances understanding of processes occurring in top cells and paves the way for further innovation in tandem solar cell development.

SourceKing Abdullah University of Science & Technology (KAUST)·JournalScience·TypeExperimental study·DateSep 4, 2025

Fast oxygen redox enabled by flexible Al–O bonds in P2-type layered oxides for sodium batteries

The study introduces a new approach to enhance energy density in sodium-ion batteries by introducing flexible Al-O bonds into P2-type layered oxides. This strategy successfully suppresses irreversible phase transitions and stabilizes local structures, significantly improving sodium-ion diffusion kinetics.

SourceHigher Education Press·JournalFrontiers in Energy·TypeExperimental study·DateSep 4, 2025

Integrative analysis of stress-responsive pathways in pearl millet under multiple abiotic challenges

This study identifies critical gene networks in pearl millet that explain its robust survival and offer molecular targets for engineering more resilient crops. The analysis reveals a complex, tissue-dependent transcriptional network that mobilizes both conserved and distinct molecular pathways to counter abiotic stress.

SourceMaximum Academic Press·JournalTropical Plants·TypeExperimental study·DateSep 4, 2025

Extreme temperatures alter species reproduction

Two studies published by the Universitat Autonoma de Barcelona team reveal how extreme temperatures impact the reproductive process in reptiles and fish. The research found that changes in temperature can increase DNA fragmentation and alter chromosomal structures, leading to increased genetic diversity and adaptation to climate change.

SourceUniversitat Autonoma de Barcelona·JournalPLOS Genetics·TypeExperimental study·DateSep 4, 2025

Korea University College of Medicine explores 'Health for Humanity' at K-CLUB International Symposium with world-renowned scholars

The Korea University College of Medicine hosted the K-CLUB International Symposium to promote interdisciplinary collaboration and address global health challenges. Distinguished global scholars explored the future of human health from diverse perspectives, including clinical care, biomedical convergence, and health policy.

Evidence appears supportive for the initiation of SGLT2 inhibitors in patients hospitalised for heart failure

In-hospital initiation of SGLT2 inhibitors did not significantly reduce short-term risk of cardiovascular death or worsening heart failure in patients admitted for heart failure. However, combining trial data shows positive effects of SGLT2 inhibitors on reducing early risk of cardiovascular death or worsening HF and all-cause mortality.

SourceEuropean Society of Cardiology·JournalCirculation·DateSep 4, 2025

New ESC/EACTS guidelines guidelines for valvular heart disease will help prevent under treatment of patients and support more equitable, higher quality care

The new guidelines provide clear practical recommendations for diagnosing and treating patients with valvular heart disease, emphasizing the importance of shared decision-making and patient-centered care. The updated guidance aims to reduce under-treatment, especially in the elderly, and promote more equitable access to high-quality care.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·DateSep 4, 2025

New guidelines for myocarditis and pericarditis aim to improve diagnosis and treatment – and help patients return to exercise and work more quickly

The new guidelines introduce a unifying term for inflammatory myopericardial syndrome and provide easy-to-use flow charts to support medical professionals in diagnosing and treating myocarditis and pericarditis. The recommendations also prioritize patient return to work and exercise, aiming to improve clinical outcomes.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·DateSep 4, 2025

Beta-blockers did not reduce cardiovascular events in selected heart attack patients in the REBOOT trial

The REBOOT trial found that beta-blocker therapy had no significant impact on all-cause death, reinfarction, or heart failure admission in patients with myocardial infarction and left ventricular ejection fraction (LVEF) ≥40%. In contrast, a meta-analysis suggests potential benefits for patients with mildly reduced LVEF (40–49%).

SourceEuropean Society of Cardiology·JournalThe Lancet·DateSep 4, 2025

Researchers reveal potential molecular link between air pollutants and increased risk of Lewy body dementia

Researchers at Johns Hopkins Medicine reveal a potential molecular link between air pollutants and an increased risk of developing Lewy body dementia. Exposure to fine particulate air pollution (PM2.5) triggered the formation of abnormal alpha-synuclein clumps in mice, similar to those found in human patients with Lewy body dementia.

SourceJohns Hopkins Medicine·JournalScience·DateSep 4, 2025

Unveiling the identity of Crohn's disease T cells

Researchers at Osaka University have identified transcription factors RUNX2 and BHLHE40 as crucial for inducing T cells involved in Crohn's disease. Overexpression of these factors promotes inflammatory cytokine production and tissue-retentive properties, making them potential novel therapeutic targets.

SourceImmunology Frontier Research Center (IFReC) - Osaka University·JournalJournal of Experimental Medicine·TypeExperimental study·DateSep 4, 2025

C-Path’s Translational Therapeutics Accelerator marks record year with seven BRIDGe awards advancing potential therapies across cancer, infectious disease, neurology and immunology

The C-Path Translational Therapeutics Accelerator has completed a record year of funding and mentorship, supporting seven projects in 2025 with approximately $2.48 million in awards. The program awarded grants to teams advancing treatments for rare liver disease, drug-resistant lung infections and pediatric brain tumors.